Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larin, K. V.
Right arrow Articles by Esenaliev, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larin, K. V.
Right arrow Articles by Esenaliev, R. O.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:2263-2267, 2002
© 2002 by the American Diabetes Association, Inc.


Emerging Treatment and Technology
Original Article

Noninvasive Blood Glucose Monitoring With Optical Coherence Tomography

A pilot study in human subjects

Kirill V. Larin, PHD1,2,3, Mohsen S. Eledrisi, MD4, Massoud Motamedi, PHD2 and Rinat O. Esenaliev, PHD1,2,3,5

1 Laboratory for Optical Sensing and Monitoring, University of Texas Medical Branch, Galveston, Texas
2 Center for Biomedical Engineering, University of Texas Medical Branch, Galveston, Texas
3 Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston, Texas
4 Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
5 Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas

OBJECTIVE—To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers.

RESEARCH DESIGN AND METHODS—An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10–20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200–600 µm from the skin surface.

RESULTS—A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers.

CONCLUSIONS—This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.

Abbreviations: 1-D, one-dimensional • 2-D, two-dimensional • ISF, interstitial fluid • NIR, near-infrared • OCT, optical coherence tomography • OGTT, oral glucose tolerance test • PC, personal computer • SMBG, self-monitoring of blood glucose


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
M. G. Ghosn, V. V. Tuchin, and K. V. Larin
Nondestructive Quantification of Analyte Diffusion in Cornea and Sclera Using Optical Coherence Tomography
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2726 - 2733.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
V. V. Sapozhnikova, D. Prough, R. V. Kuranov, I. Cicenaite, and R. O. Esenaliev
Influence of Osmolytes on In Vivo Glucose Monitoring Using Optical Coherence Tomography
Experimental Biology and Medicine, September 1, 2006; 231(8): 1323 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
A. L. Briggs and S. Cornell
Self-monitoring Blood Glucose (SMBG): Now and the Future
Journal of Pharmacy Practice, February 1, 2004; 17(1): 29 - 38.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.